drugset / Trial / NCT07426640

Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation

NCT07426640

Completed 150 enrolled Al Mouwasat Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Premature ejaculation is a common sexual condition that can cause distress for men and their partners. Different treatments are available, but some men do not respond well to standard therapies. This study was designed to evaluate whether injecting botulinum toxin type A into two areas of the penis and surrounding muscles can help delay ejaculation in men with lifelong premature ejaculation. Participants were randomly assigned to receive either botulinum toxin injections or placebo injections. The study evaluated ejaculation time, sexual satisfaction, and quality of life over a follow-up period of six months. Safety and possible side effects were also monitored during the study.

Timeline

Start
2021-11-01
Primary completion
2024-11-30
Completion
2024-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic Other

Indications